Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (2755)	5/14/1999 2:41:00 PM
From: Biomaven	Read Replies (2) of 10280

No, big difference is that before J&J was paying for everything, and now it sounds like SEPR will be paying. The crucial question is whether J&J did this because they weren't impressed with the drug, or whether it truly was a strategic decision. With the J&J imposed blanket on talking about the drug now presumably off, SEPR should now be able to disclose how the drug has been doing in its trials. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next